首页> 美国卫生研究院文献>EFSA Journal >Safety of vitamin B2 (80) as riboflavin produced by Bacillus subtilis KCCM‐10445 for all animal species
【2h】

Safety of vitamin B2 (80) as riboflavin produced by Bacillus subtilis KCCM‐10445 for all animal species

机译:枯草芽孢杆菌产生的维生素B2(80%)作为核黄素的安全性KCCM-10445适用于所有动物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Riboflavin (80%) is a feed additive produced by fermentation of a genetically modified strain. In 2014, the Panel on Additives and Products or Substances used in Animal Feed ( ) issued an opinion on the safety and efficacy of riboflavin (80%) based on a dossier supplied by the applicant. The Panel concluded that neither the production strain nor its recombinant was detected in the final product, and therefore, the additive does not give rise to any safety concern with regard to the genetic modification of the production strain. The Community Reference Laboratory on Feed additives, in the context of an official control, reported on the presence of recombinant in samples of the additive. The European Commission asked to deliver a new opinion on the safety of Vitamin B (80%) based on the new data, complementing the former one. The analysed samples contained belonging to the production strain, including the genetic modification. Moreover, one of the samples contained viable cells from the production strain. Because the production strain carries antimicrobial resistance genes introduced by the genetic modification, the Panel considers that Riboflavin (80%) poses a risk for the spread of viable cells and of a genetically modified strain‐harbouring genes coding for resistance to antimicrobials.
机译:核黄素(80%)是通过转基因菌株发酵生产的饲料添加剂。 2014年,动物饲料中使用的添加剂和产品或物质小组()根据申请人提供的卷宗对核黄素(80%)的安全性和有效性发表了意见。专家组得出结论,在最终产品中均未检测到生产菌株或其重组体,因此,该添加剂在生产菌株的基因修饰方面不会引起任何安全隐患。在官方控制下,饲料添加剂社区参考实验室报告了添加剂样品中重组体的存在。欧盟委员会要求根据新数据对维生素B(80%)的安全性发表新的意见,以补充以前的观点。分析的样品包含属于生产菌株,包括遗传修饰。此外,样品之一包含来自生产菌株的活细胞。由于生产菌株携带了通过基因修饰引入的抗药性基因,专家小组认为核黄素(80%)对活细胞和编码抗药性的基因修饰菌株携带基因的传播构成了风险。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号